A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia is driving better survival and cure rates.
Researchers at the LSU LCMC Health Cancer Center examined tumors from more than 250 Black and white women across Louisiana and uncovered key immune differences in patients with triple-negative breast cancer, one of the most aggressive forms of breast cancer.
